Relationship between plasma testosterone levels and some clinical and imaging parameters in patients with prostate cancer
Abstract
Introduction: prostate cancer is the solid tumor that appears most frequently in men older than 50 years.
Objective: to describe the relationship between plasma testosterone levels and some clinical and imaging parameters in patients with prostate cancer treated at the General Provincial Teaching Hospital in Ciego de Ávila.
Method: a cross-sectional descriptive study was carried out in the period from January 2012 to December 2015. The population studied was constituted by 117 patients with histological confirmation of the disease.
Results: groups of 76-85 years (36,75 %) and 66-75 years (34,19 %) predominated. All of them presented high levels of prostate-specific antigen, and of these 94,87 % with high risk. The majority (95,73 %) did not presented testosterone levels in castration figures. The main imaging lesions were located in the prostate (77,78 %). The tumor markers were elevated: lactate dehydrogenase (65,81 %) and alkaline phosphatase (64,10 %). Only 5,15 % of those who had affected two lobes of the prostate, had levels in castration values. 94, 51 % of the patients with testosterone levels above the castration values only presented lesions in the prostate without metastasis according to the imaging studies.
Conclusions: the results of the digital physical examination of the prostate and the imaging studies had no relation with the plasma testosterone values after the hormonal treatmentDownloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Yaisa Mileidy Parés Ojeda, Youcelín García Márquez, Sergio Adolfo Marrero Halles, Eloísa Casa Morell, Belkis Regina Toledo Franco, Thaide Trujillo Tirado
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Those authors who have publications with this journal accept the following terms of the License CC Attribution-NonCommercial 4.0 International (CC BY-NC 4.0):
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
The journal is not responsible for the opinions and concepts expressed in the works, which are the exclusive responsibility of the authors. The Editor, with the assistance of the Editorial Committee, reserves the right to suggest or request advisable or necessary modifications. Original scientific works are accepted for publication, as are the results of research of interest that have not been published or sent to another journal for the same purpose.
The mention of trademarks of specific equipment, instruments or materials is for identification purposes, and there is no promotional commitment in relation to them, neither by the authors nor by the editor.
